VergeRx for Smokers Not Ready to Quit

Study finds post-ban 'unflavoured' nicotine pouches chemically and sensorially similar to pre-ban flavoured products

This study analyzed oral nicotine pouches (ONPs) marketed before and after California's 2022 flavour ban, focusing on ZYN's 'unflavoured' po

Study finds post-ban 'unflavoured' nicotine pouches chemically and sensorially similar to pre-ban flavoured products

This study analyzed oral nicotine pouches (ONPs) marketed before and after California's 2022 flavour ban, focusing on ZYN's 'unflavoured' po

Deolane dorme em cela de outra detenta por síndrome do pânico na cadeia

Comparative Study of Oral Lesions and Dental Health in Users of Nicotine Pouches vs. Traditional Snus vs. Non-Users

This study compares oral tissue responses and dental health status among users of oral tobacco-free nicotine pouches, users of traditional o

Phase 3 Trial of Ecopipam for Tourette Syndrome: Safety and Efficacy Evaluation

This Phase 3 randomized clinical trial evaluates the safety and maintenance of effect of ecopipam, a selective dopamine D1 receptor antagoni

Phase 3 trials show orexin agonist oveporexton improves cognition, sleep, and daily function in narcolepsy type 1

Phase 3 clinical trials show that the investigational drug oveporexton (TAK-861), an oral orexin receptor 2 agonist developed by Takeda, imp

Pressão alta lidera tratamentos contínuos e costuma vir acompanhada de diabetes e colesterol alto